Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Bertrand

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Leukemia|September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group reportN Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Leukemia|March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLGJ van der Werff Ten Bosch, S Suciu, A Thyss, et al.
Bone Marrow Transplantation|March 20, 2026
Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registryZ Szmit, G Lucchini, A Bertaina, et al.
Bone Marrow Transplantation|January 24, 2017
Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)C Roux, K Tifratene, G Socié, et al.
Leukemia|June 9, 2015
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951E Clappier, N Grardel, M Bakkus, et al.
Leukemia|September 26, 2013
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletionsE Clappier, M F Auclerc, J Rapion, et al.
The Journal of Clinical Investigation|January 23, 2025
Human oncostatin M deficiency underlies an inherited severe bone marrow failure syndromeAlexandrine Garrigue, Laëtitia Kermasson, Sandrine Susini, et al.
Bone Marrow Transplantation|December 13, 2016
Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experienceA-L Alloin, G Leverger, J-H Dalle, et al.
Leukemia|October 17, 2012
Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALLR Garand, K Beldjord, H Cavé, et al.
Clinical and Experimental Immunology|September 21, 2020
Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBBM Mollin, S Beaumel, B Vigne, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Leukemia|September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group reportN Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Leukemia|March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLGJ van der Werff Ten Bosch, S Suciu, A Thyss, et al.
Bone Marrow Transplantation|March 20, 2026
Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registryZ Szmit, G Lucchini, A Bertaina, et al.
Bone Marrow Transplantation|January 24, 2017
Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)C Roux, K Tifratene, G Socié, et al.
Leukemia|June 9, 2015
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951E Clappier, N Grardel, M Bakkus, et al.
Leukemia|September 26, 2013
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletionsE Clappier, M F Auclerc, J Rapion, et al.
The Journal of Clinical Investigation|January 23, 2025
Human oncostatin M deficiency underlies an inherited severe bone marrow failure syndromeAlexandrine Garrigue, Laëtitia Kermasson, Sandrine Susini, et al.
Bone Marrow Transplantation|December 13, 2016
Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experienceA-L Alloin, G Leverger, J-H Dalle, et al.
Leukemia|October 17, 2012
Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALLR Garand, K Beldjord, H Cavé, et al.
Clinical and Experimental Immunology|September 21, 2020
Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBBM Mollin, S Beaumel, B Vigne, et al.
Pageof 21